Pfizer Limited (BOM:500680)
India
· Delayed Price · Currency is INR 4,094.55
-18.05 (-0.44%)
At close: Feb 21, 2025
Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of INR 187.34 billion. The enterprise value is 165.28 billion.
| Market Cap | 187.34B |
| Enterprise Value | 165.28B |
Important Dates
The last earnings date was Friday, February 14, 2025.
| Earnings Date | Feb 14, 2025 |
| Ex-Dividend Date | Aug 21, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 30.44.
| PE Ratio | 30.44 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 5.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.85 |
| EV / Sales | 7.39 |
| EV / EBITDA | 24.49 |
| EV / EBIT | 25.50 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | n/a |
| Interest Coverage | 51.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.23% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 12.99M |
| Profits Per Employee | 3.58M |
| Employee Count | 1,721 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.11% |
| 50-Day Moving Average | 4,740.18 |
| 200-Day Moving Average | 5,141.73 |
| Relative Strength Index (RSI) | 24.06 |
| Average Volume (20 Days) | 1,679 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of INR 22.36 billion and earned 6.16 billion in profits. Earnings per share was 134.53.
| Revenue | 22.36B |
| Gross Profit | 14.33B |
| Operating Income | 6.48B |
| Pretax Income | 8.34B |
| Net Income | 6.16B |
| EBITDA | 6.36B |
| EBIT | 6.48B |
| Earnings Per Share (EPS) | 134.53 |
Balance Sheet
The company has 22.81 billion in cash and 747.00 million in debt, giving a net cash position of 22.07 billion.
| Cash & Cash Equivalents | 22.81B |
| Total Debt | 747.00M |
| Net Cash | 22.07B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 37.51B |
| Book Value Per Share | 819.81 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 64.09%, with operating and profit margins of 28.98% and 27.53%.
| Gross Margin | 64.09% |
| Operating Margin | 28.98% |
| Pretax Margin | 37.30% |
| Profit Margin | 27.53% |
| EBITDA Margin | 28.46% |
| EBIT Margin | 28.98% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | 35.00 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | -12.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.84% |
| Earnings Yield | 3.29% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |